TP53 and cancer: These mutations include MDM2 amplification and loss of ataxia telangiectasia-mutated (ATM) gene, encoding a protein involved in DNA repair, and both occurred commonly in luminal B tumors, indicating that the TP53 pathway remained largely intact in the majority of malignant tumors.